retatrutide phase 2 trial obesity nejm 2023 triple agonist new england journal of medicine Triple–Hormone-Receptor Retatrutide for — Lilly Reports Up to 28.3%
Pay in 4 interest-free payments of $7.18 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23























